Opening Pandora's Bread Box: The Critical Role of Wheat Lectin in Human Disease
by Sayer Ji
Now that celiac disease has been allowed official entry into the annals of established medical conditions, and gluten intolerance is no longer entirely a fringe medical concept, the time has come to draw attention to the powerful little chemical in wheat known as 'wheat germ agglutinin' (WGA) which is largely responsible for many of wheat's pervasive, and difficult-to-diagnose, ill effects. Not only does WGA throw a monkey wrench into our assumptions about the primary causes of wheat intolerance, it also pulls the rug out from under one of the health food industry's favorite poster children since high concentrations of WGA is found in "whole wheat," including its supposedly superior sprouted form. Below the radar of conventional serological testing for antibodies against various gluten proteins and genetic testing for disease susceptibility, the WGA "lectin problem" remains almost entirely obscured. Lectins, though found in all grains, seeds, legumes, dairy and our beloved nightshades: the tomato and potato, are rarely connected with health or illness, even when their consumption may greatly reduce both the quality and length of our lives.
Although significant progress has been made in exposing the dark side of wheat  over the past decade, gluten receives a disproportionate share of the attention. Given that modern bread wheat (Triticum aestivum) is an allohexaploid species containing six distinct sets of chromosomes capable of producing well over 23,000 unique proteins, it is not surprising that we are only now beginning to unravel the complexities of this plant’s many secrets.  What is unique about WGA is that it can do direct damage to the majority of tissues in the human body without requiring a specific set of genetic susceptibilities and/or immune-mediated articulations. This may explain why chronic inflammatory and degenerative conditions are endemic to wheat-consuming populations even when overt allergies or intolerances to wheat gluten appear exceedingly rare. The future fate of wheat consumption and, by implication, our health, may depend largely on whether or not the toxic qualities of WGA come to light within the general population.
Nature engineers, within all species, a set of defenses against predation, though not all are as obvious as the thorns on a rose or the horns on a rhinoceros. Plants do not have the cell-mediated immunity of higher life forms, like ants, nor do they have the antibody-driven, secondary immune systems of vertebrates with jaws. Therefore, they must rely on a much simpler, innate immunity. It is for this reason that seeds of the grass family, e.g. rice, wheat, spelt, rye, have exceptionally high levels of defensive glycoproteins known as lectins, which function much like "invisible thorns." Cooking, sprouting, fermentation and digestion are the traditional ways in which people, for instance, deal with the various anti-nutrients found within this family of plants, However, lectins are, by design, particularly resistant to degradation through a wide range of pH and temperatures.
WGA lectin is an exceptionally tough adversary as it is formed by the same disulfide bonds that make vulcanized rubber (as used in bowling bowls) and human hair so strong, flexible and durable. Like synthetic pesticides, lectins are extremely small, resistant to decomposition by living systems, and tend to accumulate and incorporate into tissues where they interfere with normal biological processes. Indeed, WGA lectin is so powerful as an insecticide that biotech firms have used recombinant DNA technology to create genetically modified WGA-enhanced plants. We can only hope that these virtually unregulated biotech companies, in the business of playing God with the genetic infrastructure of life, will realize the potential harm to humans that such genetic modifications can cause.
Lectins are sugar-binding proteins and, through thousands of years of selectively breeding wheat for increasingly larger quantities of protein, the concentration of WGA lectin has increased proportionately. This, no doubt, has contributed to wheat’s global dominance as one of the world’s favored monocultures, offering additional "built-in" pest resistance. The word lectin comes from the same etymological root as the word select, and literally means "to choose." Lectins are designed "to choose" specific carbohydrates that project from and attach to the surface of cells. In the case of WGA, the two glycoproteins it selects, in order of greatest affinity, are N-Acetyl Glucosamine and N-Acetylneuraminic acid (sialic acid).
WGA is nature's ingenious solution for protecting the wheat plant from the entire gamut of its natural enemies. Fungi have cell walls composed of a polymer of N-Acetylglucosamine. The cellular walls of bacteria are made from a layered structure called the peptidoglycan, a biopolymer of N-Acetylglucosamine. N-Acetylglucosamine is the basic unit of the biopolymer chitin, which forms the outer coverings of insects and crustaceans (shrimp, crab, etc.). All animals, including worms, fish, birds and humans, use N-Acetyglucosamine as a foundational substance for building the various tissues in their bodies, including the bones. The production of cartilage, tendons, and joints depends on the structural integrity of N-Acetylglucosamine. The mucous known as the glycocalyx, or literally, "sugar coat" is secreted in humans by the epithelial cells which line all the mucous membranes, from nasal cavities at the top to the alimentary tube at the bottom, as well as the protective and slippery lining of our blood vessels. The glycocalyx is composed largely of N-Acetylglucosamine and N-Acetylneuraminic acid (also known as sialic acid), with carbohydrate end of N-Acetylneuraminic acid of this protective glycoprotein forming the terminal sugar that is exposed to the contents of both the gut and the arterial lumen (opening). WGA's unique binding specificity to these exact two glycoproteins is not accidental. Nature has perfectly designed WGA to attach to, disrupt, and gain entry through these mucosal surfaces.
It may strike some readers as highly suspect that wheat - the "staff of life" - which has garnered a reputation for "wholesome goodness" the world over, could contain a powerful health-disrupting anti-nutrient, which is only now coming to public attention. WGA has been overshadowed by the other proteins in wheat. Humans – not nature – have spent thousands of years cultivating and selecting for larger and larger quantities of these proteins. These pharmacologically active, opiate-like proteins in gluten are known as gluten exorphins (A5, B4, B5, C) and gliadorphins. In the short term, they may effectively anesthetize us to the long-term, adverse effects of WGA. Gluten also contains exceptionally high levels of the excitotoxic l-aspartic and l-glutamic amino acids, which can also be highly addictive, not unlike their synthetic shadow molecules aspartame and monosodium glutamate. In a previous article on the topic, The Dark Side of Wheat: New Perspectives on Celiac Disease and Wheat Intolerance, we explored the role that these psychotropic qualities in grains played in ushering in civilization at the advent of the Neolithic transition, around 10,000 BC. No doubt the narcotic properties of wheat is the primary reason why suspicions about its toxicity have remained merely speculative for thousands upon thousands of years.
WGA is most concentrated in the seed of the wheat plant, likely due to the fact that the seeds are the "babies" of these plants and are invested with the entire hope for continuance of their species. Protecting the seed against predation is necessarily a first priority. WGA is an exceedingly small glycoprotein (36 kilodaltons) and is concentrated deep within the embryo of the wheat berry (approximately 1 microgram per grain). WGA migrates during germination to the roots and tips of leaves, as the developing plant begins to project itself into the world and outside the safety of its seed. In its quest for nourishment from the soil, its roots are challenged with fungi and bacteria that seek to invade the plant. In its quest for sunlight and other nourishment from the heavens, the plant’s leaves become prey to insects, birds, mammals, etc. Even after the plant has developed beyond the germination and sprouting stages, it retains almost 50% of the levels of lectin found in the dry seeds. Approximately one third of this WGA is in the roots and two thirds is in the shoot, for at least 34 days 
Each grain contains about one microgram of WGA. That seems hardly enough to do any harm to animals our size. Lectins, however, are notoriously dangerous even in minute doses and can be fatal when inhaled or injected directly into the bloodstream. According to the Centers for Disease Control and Prevention, it takes only 500 micrograms (about half a grain of sand) of ricin (a lectin extracted from castor bean casings) to kill a human. A single, one ounce slice of wheat bread contains approximately 500 micrograms of WGA, which, if it were refined to its purest form and injected directly into the blood, could, in theory, have platelet-aggregating and erythrocyte-agglutinizing effects strong enough to create an obstructive clot such as that occuring in myocardial infarction and stroke. This, however, is not a likely route of exposure and, in reality, the immediate pathologies associated with lectins like ricin and WGA are largely restricted to the gastrointestinal tract where they can cause mucosal injuries. The point is that WGA, even in small quantities, could have profoundly adverse effects, given suitable conditions. Ironically, WGA is exceptionally small, at 36 kilodaltons (approximately the mass of 36,000 hydrogen atoms) and it can pass through the cell membranes of the intestine with ease. The intestines will allow passage of molecules up to 1,000 kilodaltons in size. Moreover, one wheat kernel contains 16.7 trillion individual molecules of WGA, with each molecule of WGA having four N-Acetylglucosamine binding sites. The disruptive and damaging effects of whole wheat bread consumption are formidable in someone whose protective mucosal barrier has been compromised by something as simple as nonsteroidal anti-inflammatory drug (NSAID) use, or a recent viral or bacterial infection. The common consumption of both wheat and NSAIDs may suggest the frequency of the WGA vicious cycle. Anti-inflammatory medications, such as ibuprofen and aspirin, increase intestinal permeabilty and may cause absorption of even larger-than-normal quantities of pro-inflammatory WGA. Conversely, the inflammation caused by the absorption of WGA lectin is the very reason there is a great need for the inflammation-reducing effects of NSAIDs.
One way to gauge just how pervasive the adverse effects of WGA are among wheat-consuming populations is the popularity of the dietary supplement glucosamine. In the USA, a quarter-billion dollars’ worth of glucosamine is sold annually. The main source of glucosamine on the market is from the N-Acetylglucosamine-rich chitin exoskelotons of crustaceans like shrimp and crab. Glucosamine is used for reducing pain and inflammation. We do not have a dietary deficiency of the pulverized shells of dead sea critters, just as our use of NSAIDs is not caused by a deficiency of these synthetic chemicals in our diet. When we consume glucosamine supplements, the WGA, instead of binding to our tissues, binds to the pulverized chitin in the glucosamine supplements, sparing us from the full impact of WGA. Many millions of Americans who have greatly reduced their pain and suffering by ingesting glucosamine and NSAIDs may be better served by removing wheat, the underlying cause of their malaise, from their diets. This would result in even greater relief from pain and inflammation along with far less dependency on both palliative supplements and medicines.
To further underscore this point, the following are several ways that WGA depletes our health while glucosamine works against it:
WGA may be Pro-inflammatory
At exceedingly small (nanomolar) concentrations, WGA stimulates the synthesis of pro-inflammatory chemical messengers (cytokines) including Interleukin 1, Interleukin 6 and Interleukin 8 in intestinal and immune cells. WGA has been shown to induce NADPH-Oxidase in human neutrophils associated with the "respiratory burst" that results in the release of inflammatory free radicals called reactive oxygen species WGA has been shown to play a causative role in patients with chronic thin gut inflammation.
WGA may be Immunotoxic
WGA induces thymus atrophy in rats and may directly bind to, and activate, leukocytes . Anti-WGA antibodies in human sera have been shown to cross-react with other proteins, indicating that they may contribute to autoimmunity . Indeed, WGA appears to play a role in the pathogenesis of celiac disease (CD) that is entirely distinct from that of gluten, due to significantly higher levels of the immunoglobulins IgG and IgA antibodies against WGA found in patients with CD, when compared with patients with other intestinal disorders. These antibodies have also shown not to cross-react with gluten antigens 
WGA may be Neurotoxic
WGA can pass through the blood brain barrier (BBB) through a process called "adsorptive endocytosis" and is able to travel freely among the tissues of the brain which is why it is used as a marker for tracing neural circuits. WGA’s ability to pass through the BBB, pulling bound substances with it, has piqued the interest of pharmaceutical developers who are looking to find ways of delivering drugs to the brain. WGA has a unique binding affinity for N-Acetylneuraminic acid, a crucial component of neuronal membranes found in the brain, such as gangliosides which have diverse roles such as cell-to-cell contact; ion conductance, as receptors, and whose dysfunction has been implicated in neurodegenerative disorders. WGA may attach to the protective coating on the nerves known as the myelin sheath and is capable of inhibiting nerve growth factor  which is important for the growth, maintenance, and survival of certain target neurons. WGA binds to N-Acetylglucosamine which is believed to function as an atypical neurotransmitter functioning in nocioceptive (pain) pathways.
WGA may be Cytotoxic
WGA has been demonstrated to be cytotoxic to both normal and cancerous cell lines, capable of inducing either cell cycle arrest or programmed cell death (apoptosis).
WGA may interfere with Gene Expression
WGA demonstrates both mitogenic and anti-mitogenic  activities. WGA may prevent DNA replication WGA binds to polysialic acid (involved in post-translational modifications) and blocks chick tail bud development in embryogenesis, indicating that it may influence both genetic and epigenetic factors.
WGA may disrupt Endocrine Function
WGA has also been shown to have an insulin-mimetic action, potentially contributing to weight gain and insulin resistance . WGA has been implicated in obesity and "leptin resistance" by blocking the receptor in the hypothalamus for the appetite satiating hormone leptin. WGA stimulates epidermal growth factor which, when upregulated, is associated with increased risk of cancer. WGA has a particular affinity for thyroid tissue and has been shown to bind to both benign and malignant thyroid nodules  WGA interferes with the production of secretin from the pancreas, which can inhibit with digestion and cause pancreatic hypertrophy. WGA attaches to sperm and ovary cells, indicating it may adversely influence fertility.
WGA may be Cardiotoxic
WGA induces platelet activation and aggregration . WGA has a potent, disruptive effect on platelet endothelial cell adhesion molecule-1, which plays a key role in tissue regeneration and safely removes neutrophils from our blood vessels.
WGA may adversely effect Gastrointestinal Function
WGA causes increased shedding of the intestinal brush border membrane, reduction in surface area, acceleration of cell losses and shortening of villi, via binding to the surface of the villi. WGA can mimic the effects of epidermal growth factor (EGF) at the cellular level, indicating that the crypt hyperplasia seen in celiac disease may be due to the growth-promoting effects of WGA. WGA causes cytoskeletal degradation in intestinal cells, contributing to cell death and increased turnover. WGA decreases levels of heat shock proteins in gut epithelial cells leaving these cells less well protected against the potentially harmful content of the gut lumen.
WGA may share pathogenic similarities with certain Viruses
There are a number of interesting similarities between WGA lectin and viruses. Both viral particles and WGA lectin are several orders of magnitude smaller than the cells they enter, and subsequent to their attachment to the cell membrane, are taken into the cell through a process of endocytosis. Both influenza and WGA gain entry through the sialic acid coatings of our mucous membranes (glycocalyx) each with a sialic acid-specific substance: the neuraminidase enzyme for viruses and the sialic acid binding sites on the WGA lectin.Once the influenza virus and WGA lectin have made their way into wider circulation in the host body, they are both capable of blurring the line in the host between self and non-self. Influenza accomplishes this by incorporating itself into the genetic material of our cells and taking over the protein production machinery to replicate itself, with the result that our immune system must attack its own virally transformed cell, to clear the infection. Studies done with herpes simplex virus have shown that WGA has the capacity to block viral infectivity through competitively binding to the same cell surface receptors, indicating that they may effect cells through very similar pathways. WGA has the capability of influencing the gene expression of certain cells, e.g. mitogenic/anti-mitogenic action, and like other lectins associated with autoimmunity, e.g. soy lectin, and viruses like Epstein-Barr virus, WGA may be capable of causing certain cells to exhibit class 2 human leukocyte antigens (HLA-II), which mark them for autoimmune destruction by white blood cells. Since human antibodies to WGA have been shown to cross-react with other proteins, even if WGA does not directly transform the phenotype of our cells into "other," the resulting cross-reactivity of antibodies to WGA with our own cells would nonetheless result in autoimmunity.
Given the multitude of ways in which WGA may disrupt our health, gain easy entry through our intestine into systemic circulation, and remain refractory to traditional antibody-based clinical diagnoses, it is altogether possible that the consumption of wheat is detracting from the general health of the wheat-consuming world and that we have been, for all these years, "digging our graves with our teeth." This perspective may come as a great surprise to the health food industry whose particular love affair for whole wheat products has begun to go mass market. The increasingly hyped-up marketing of "whole wheat," "sprouted grain," and "wheat germ" enriched products, all of which may have considerably higher levels of WGA than their processed, fractionized, non-germinated and supposedly "less healthy" equivalents, may contribute to making us all significantly less healthy.
It is my belief that a careful study of the wheat plant will reveal that, despite claims to the contrary, man does not have dominion over nature. All that he deems fit for his consumption may not be his inborn right. Though the wheat plant’s apparently defenseless disposition would seem to make it suitable for mass human consumption, it has been imbued with a multitude of invisible "thorns," with WGA being its smallest and perhaps most potent defense against predation. While WGA may be an uninvited guest at our table, wheat is equally inhospitable to us. Perhaps the courteous thing to do, having realized our mistaken intrusion, is to lick our wounds and simply go our separate ways. Perhaps, as we separate from our infatuation with wheat, we will grow more sensitive to our bodies’ true needs and discover far more suitable forms of nourishment that nature has not impregnated with such high levels of addictive and potentially debilitating proteins.
 Ji, Sayer. “The Dark Side of Wheat: New Perspectives on Celiac Disease & Wheat Intolerance.” Journal of Gluten Sensitivity. Santa Rosa: www.celiac.com, 2008. http://www.greenmedinfo.com/page/dark-side-wheat-new-perspectives-celiac-disease-wheat-intolerance-sayer-ji. (October 2012).
 Desmond, S. T. Nicholl. An Introduction to Genetic Engineering 3rd Ed. Cambridge: Cambridge University Press, 1994-2008, https://www.cambridge.org/aus/catalogue/catalogue.asp?isbn=9780521615211. (October 2012),
 Mishkind, Michael, Kenneth Keegstra, Barry A. Palevitz. “Distribution of Wheat Germ Agglutinin in Young Wheat Plants.” Plant Physiology. Rockville: American Society of Plant Biologists, 1980. http://www.plantphysiol.org/content/66/5/950.full.pdf. (December 2012).
 Pellegrina, Chiara Dalla, Omar Perbellini, Maria Teresa Scupoli, Carlo Tomelleri, Chiara Zanetti, Gianni Zoccatelli, Marina Fusi, Angelo Peruffo, Corrado Rizzi, Roberto Chignola. “Effects of Wheat Germ Agglutinin on Human Gastrointestinal Epithelium: Insights From an Experimental Model of Immune/epithelial Cell Interaction.” Toxicology and Applied Pharmacology. Amsterdam: Elsevier B.V.., 2009. http://www.deepdyve.com/lp/elsevier/effects-of-wheat-germ-agglutinin-on-human-gastrointestinal-epithelium-DDDhjGaQzd/1. (January 2013)
 Karlsson, A. “Wheat Germ Agglutinin Induces NADPH-oxidase Activity in Human Neutrophils by Interaction with Mobilizable Receptors.” Infection and Immunity. Washington, DC: The American Society for Microbiology, 1999. http://www.ncbi.nlm.nih.gov/pubmed/10377127. (December 2012)
 Guzyeyeva, Gloria V. “Lectin Glycosylation as a Marker of Thin Gut Inflammation.” The FASEB Journal. Bethesda: Federation of American Societies For Experimental Biology, 2008. http://www.fasebj.org/cgi/content/meeting_abstract/22/1_MeetingAbstracts/898.3. (October 2012).
 Pusztai, A., S.W.B. Ewen, G. Grant, D.S. Brown, J.C. Stewart, W.J. Peumans, E.J.M Van Damme, S. Bardocz. “Antinutritive Effects of Wheat-germ Agglutinin and Other N-Acetylglucosamine-specific Lectins.” The British Journal of Nutrition. Cambridge: Cambridge University Press, 1993. http://journals.cambridge.org/download.php?file=%2FBJN%2FBJN70_01%2FS0007114593001254a.pdf&code=ad7ed0ca7f0f2f23215d621ee092fd 38. (September 2012)
 Tyrrell, Gregory J., Mark S. Peppler, Robert A. Bonnah, Clifford G. Clark, Pele Chong, Glen D. Armstrong. “Lectinlike Properties of Pertussis Toxin”. Infection and Immunity. Washington, D.C.: The American Society for Microbiology, 1989. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC313367/pdf/iai00066-0224.pdf. (November 2012).
 Tchernychev, B., M. Wilchek. “Natural Human Antibodies to Dietary Lectins.” FEBS Letters. Amsterdam: Elsevier BV, 1996. http://www.ncbi.nlm.nih.gov/pubmed/8955334. (January 2013).
 Sollid, L.M., J. Kolberg, H. Scott, J. Ek, O. Fausa, P. Brandtzaeg. “Antibodies to Wheat Germ Agglutinin in Coeliac Disease.” Clinical & Experimental Immunology Hoboken: Wiley-Blackwell Publishing 1986. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1577348/. (November 2012).
 Faith-Magnusson, K., KE. Magnussen. “Elevated Levels of Serum Antibodies to the Lectin Wheat Germ Agglutinin in Celiac Children Lend Support to the Gluten-lectin Theory of Celiac Disease.” Pediatrid Allergy & Immunology. Hoboken: Wiley-Blackwell Publishing. 1995. http://www.ncbi.nlm.nih.gov/pubmed/7581728#. (September 2012).
 Broadwell, R.D., B. J. Balin, M. Salcman. “Transcytotic Pathway for Blood-borne Protein Through the Blood-brain Barrier.” Proceedings of the National Academy of Sciences of the United States of America. Washington, DC: National Academy of Sciences. 1988. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC279605/. (December 2012).
 Damak, S., B. Mosinger, RF Margolskee. “Transsynaptic Transport of Wheat Germ Agglutinin Expressed in a Subset of Type II Taste Cells of Transgenic Mice.” BMC Neuroscience. London: BioMed Central, Ltd. 2008. http://www.ncbi.nlm.nih.gov/pubmed/18831764#. (December 2012).
 Dolapchieva, S. “Distribution of Concanavalin A and Wheat Germ Agglutinin Binding Sites in the Rat Peripheral Nerve Fibres Revealed by Lectin/glycoprotein-gold Histochemistry”. The Histochemical Journal. London: Chapman & Hall, 1996. http://link.springer.com/article/10.1007%2FBF02331422?LI=true#page-1. (January 2013).
 Hashimoto, S., A. Hagino. “Wheat germ agglutinin, concanavalin A, and lens culinalis agglutinin block the inhibitory effect of nerve growth factor on cell-free phosphorylation of Nsp100 in PC12h cells.” Cell Structure and Function Journal. Kyoto: Nihon Saibo Seibutsu Gakkai. 1989. http://www.ncbi.nlm.nih.gov/pubmed/2720800#. (September 2012).
 Liu, W.K., S.C. Sze, J.C. Ho, B.P. Liu, M.C. Yu. “Wheat Germ Lectin Induces G2/M Arrest in Mouse L929 Fibroblasts.” Journal of Cellular Biochemistry. Hoboken: Wiley-Blackwell Publishing. 2004. http://www.unboundmedicine.com/medline/citation/15048871/Wheat_germ_lectin_induces_G2/M_arrest_in_mouse_L929_fibroblasts_. (November 2012).
 Kaplowitz, Paul B. “Wheat germ agglutinin and concanavalin A inhibit the response of human fibroblasts to peptide growth factors by a post-receptor mechanism. Journal of Cellular Physiology. Hoboken: Wiley-Blackwell Publishing. 1985. http://onlinelibrary.wiley.com/doi/10.1002/jcp.1041240317/abstract. (October 2012).
 Cox, Lynne S. “DNA Replication in Cell-free Extracts from Xenopus Eggs is Prevented by Disrupting Nuclear Envelope Function”. Journal of Cell Science. Cambridge: The Company of Biologists. 1992, http://jcs.biologists.org/content/101/1/43.long. (October 2012).
 Yevdokimova, N.Y., A.S. Yefimov. “Effects of Wheat Germ Agglutinin and Concanavalin A on the Accumulation of Glycosaminoglycans in Pericellular Matrix of Human Dermal Fibroblasts. A Comparison with Insulin”. Acta Biochimica Polonica. Warsaw: The Polish Biochemical Society and the Committee of Chemistry and Biophysics. 2001. http://www.ncbi.nlm.nih.gov/pubmed/11732625. (November 2012).
 Sasano, H., M. Rojas, S.G. Silverberg. “Analysis of Lectin Binding in Benign and Malignant Thyroid Nodules.” Pathology & Laboratory Medicine. Northfield: The College of American Pathologists. 1989. http://europepmc.org/abstract/MED/2916907/reload=0;jsessionid=KYN2j0u7h2Zg8CT6OZ2D.2. (January 2013).
 Lebret, M., F. Rendu. “Further Characterization of Wheat Germ Agglutinin Interaction with Human Platelets: Exposure of Fibrinogen Receptors.” Journal of Thrombosis and Haemostasis. UK: Blackwell Publishing. 1986. http://www.ncbi.nlm.nih.gov/pubmed/3105108. (September 2012).
 Ohmori, T., Y. Yatomi, Y. Wu, M. Osada, K. Satoh, Y. Ozaki. “Wheat Germ Agglutinin-induced Platelet Activation via Platelet Endothelial Cell Adhesion Molecule-1: Involvement of Rapid Phospholipase C Gamma 2 Activation by Src Family Kinases.” Biochemistry. New York: Bedford, Freeman & Worth. 2001. http://www.ncbi.nlm.nih.gov/pubmed/11669637. (November 2012).
 Ovelgonne, J.H., J.F.J.G. Koninkx, A. Pusztai, S. Bardocz, W. Kok, S.W.B. Ewen, H.G.C.J.M. Hendriks, J.E. van Dijk. “Decreased Levels of Heat Shock Proteins in Gut Epithelial Cells After Exposure to Plant Lectins.” Gut. London: BMJ Group. 2000. http://gut.bmj.com/content/46/5/680. (September 2012).